US 11220496
Compounds and method for treating autoimmune diseases
granted A61KA61K31/506A61K31/675
Quick answer
US patent 11220496 (Compounds and method for treating autoimmune diseases) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/506, A61K31/675, A61K45/06, A61P